NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses—Therapeutic Perspectives

Newcastle disease virus strain AF2240 as an oncolytic virus: A review

(2018) Jeevanathan Kalyanasundram et al.   ACTA TROPICA

Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?

(2018) Giuseppe Badalamenti et al.   CELLULAR IMMUNOLOGY

Oncorine, the World First Oncolytic Virus Medicine and its Update in China

(2018) Min Liang   CURRENT CANCER DRUG TARGETS

TRAIL/NF-κB/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines

(2018) Claudia Geismann et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment

(2018) M. Garofalo et al.   JOURNAL OF CONTROLLED RELEASE

Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model

(2018) Lukasz Kuryk et al.   JOURNAL OF MEDICAL VIROLOGY

Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones

(2018) Nikolas Tim Martin et al.   MOLECULAR THERAPY

Targeting IκappaB kinases for cancer therapy

(2018) Nikee Awasthee et al.   SEMINARS IN CANCER BIOLOGY

Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies

(2018) Shashi Gujar et al.   TRENDS IN IMMUNOLOGY

NF-kappaB: Two Sides of the Same Coin

(2018) Bruno Pires et al.   Genes

Designer Oncolytic Adenovirus: Coming of Age

(2018) Alexander Baker et al.   Cancers

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations

(2018) Judith A. Seidel et al.   Frontiers in Oncology

Principles of adoptive T cell therapy in cancer

(2018) Özcan Met et al.   Seminars in Immunopathology

Designing and building oncolytic viruses

(2017) Justin Maroun et al.   Future Virology

Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes

(2017) Marie Rouanet et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update

(2017) Sébastien A. Felt et al.   JOURNAL OF GENERAL VIROLOGY

Oncolytic virus-induced cell death and immunity: a match made in heaven?

(2017) Jolien De Munck et al.   JOURNAL OF LEUKOCYTE BIOLOGY

T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy

(2017) Robert Sackstein et al.   LABORATORY INVESTIGATION

The nuclear factor-kappa B pathway and response to treatment in breast cancer

(2017) Yeon Hee Park   PHARMACOGENOMICS

Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers

(2017) Dylan J. Fehl et al.   VIRUS RESEARCH

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity

(2017) Assia Angelova et al.   Viruses-Basel

VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma

(2017) Xiaosai Yao et al.   Cancer Discovery

Review: Oncolytic virotherapy, updates and future directions

(2017) Christos Fountzilas et al.   Oncotarget

Oncolytic Herpes Simplex Viral Therapy: A Stride toward Selective Targeting of Cancer Cells

(2017) Dhaval S. Sanchala et al.   Frontiers in Pharmacology

Trial Watch: Adoptively transferred cells for anticancer immunotherapy

(2017) Carole Fournier et al.   OncoImmunology

Oncolytic Viruses—Natural and Genetically Engineered Cancer Immunotherapies

(2017) Sachin R. Jhawar et al.   Frontiers in Oncology

Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy

(2017) Daniel E. Meyers et al.   Frontiers in Oncology

PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer

(2017) Chandini Thirukkumaran et al.   PLoS One

UV-inactivated HSV-1 potently activates NK cell killing of leukemic cells

(2016) Ismael Samudio et al.   BLOOD

Oncolytic virus therapy: A new era of cancer treatment at dawn

(2016) Hiroshi Fukuhara et al.   CANCER SCIENCE

Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor- B Signaling for Cancer Treatment

(2016) K. P. Zeligs et al.   CLINICAL CANCER RESEARCH

STAT1 and NF- B Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells

(2016) J. D. Jackson et al.   MOLECULAR CANCER RESEARCH

Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity

(2016) M. Garofalo et al.   MOLECULAR CANCER THERAPEUTICS

Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer

(2016) Fang Huang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Signaling via the NFκB system

(2016) Simon Mitchell et al.   Wiley Interdisciplinary Reviews-Systems Biology and Medicine

A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1

(2016) Kai Li et al.   Oncotarget

Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers

(2016) Tuuli Ranki et al.   Journal for ImmunoTherapy of Cancer

Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches

(2016) Mi Park et al.   Cells

NF-κB in cancer therapy

(2015) Feng Li et al.   ARCHIVES OF TOXICOLOGY

AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation

(2015) Maria Victoria Maliandi et al.   Molecular Cancer

Oncolytic Replication of E1b-Deleted Adenoviruses

(2015) Pei-Hsin Cheng et al.   Viruses-Basel

Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway

(2015) Wei-Choong Ch’ng et al.   CELLULAR ONCOLOGY

The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma

(2015) Carmela Passaro et al.   Oncotarget

Recent advances on viral manipulation of NF-κB signaling pathway

(2015) Jun Zhao et al.   Current Opinion in Virology

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma

(2015) Cristian Capasso et al.   OncoImmunology

Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer

(2015) L Vassilev et al.   OncoImmunology

Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment

(2015) Robert HI Andtbacka et al.   Journal for ImmunoTherapy of Cancer

NF-κB in Cellular Senescence and Cancer Treatment

(2014) Hua Jing et al.   MOLECULES AND CELLS

Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus

(2014) Slawomir Antoszczyk et al.   NEURO-ONCOLOGY

Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis

(2013) Y Kulu et al.   CANCER GENE THERAPY

Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo

(2013) Danielle N. Yarde et al.   EXPERIMENTAL HEMATOLOGY

Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF- B-Dependent Autophagy

(2013) L. Shulak et al.   JOURNAL OF VIROLOGY

Adenovirus E1B 19-Kilodalton Protein Modulates Innate Immunity through Apoptotic Mimicry

(2013) J. R. Radke et al.   JOURNAL OF VIROLOGY

The complexity of NF-κB signaling in inflammation and cancer

(2013) Bastian Hoesel et al.   Molecular Cancer

Activation of p53 by Chemotherapeutic Agents Enhances Reovirus Oncolysis

(2013) Da Pan et al.   PLoS One

Oncosuppressive Suicide Gene Virotherapy “PVH1-yCD/5-FC” for Pancreatic Peritoneal Carcinomatosis Treatment: NFκB and Akt/PI3K Involvement

(2013) Soukaina Réjiba et al.   PLoS One

The Oncolytic Effect of Respiratory Syncytial Virus (RSV) in Human Skin Cancer Cell Line, A431

(2013) Vahid Salimi et al.   Iranian Red Crescent Medical Journal

Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy

(2012) L Zhang et al.   GENE THERAPY

NF- B, the first quarter-century: remarkable progress and outstanding questions

(2012) M. S. Hayden et al.   GENES & DEVELOPMENT

The noncanonical NF-κB pathway

(2012) Shao-Cong Sun   IMMUNOLOGICAL REVIEWS

Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer

(2012) Albert S. Baldwin   IMMUNOLOGICAL REVIEWS

Activation of the human immune system via toll-like receptors by the oncolytic parvovirus H-1

(2012) Maike Sieben et al.   INTERNATIONAL JOURNAL OF CANCER

Inhibition of Type I Interferon-Mediated Antiviral Action in Human Glioma Cells by the IKK Inhibitors BMS-345541 and TPCA-1

(2012) Ziyun Du et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Curative one-shot systemic virotherapy in murine myeloma

(2012) S Naik et al.   LEUKEMIA

An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance

(2012) Vincenzo Cerullo et al.   MOLECULAR THERAPY

The encephalomyocarditis virus

(2012) Margot Carocci et al.   Virulence

Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense

(2011) Ibtissam Echchgadda et al.   BMC CANCER

Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation

(2011) D Pan et al.   BRITISH JOURNAL OF CANCER

Oncolytic virotherapy for pancreatic cancer

(2011) Sonia Wennier et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Non-canonical NF-κB signaling pathway

(2010) Shao-Cong Sun   CELL RESEARCH

A single NFκB system for both canonical and non-canonical signaling

(2010) Vincent Feng-Sheng Shih et al.   CELL RESEARCH

Oncolytic targeting of renal cell carcinomaviaencephalomyocarditis virus

(2010) Frederik C. Roos et al.   EMBO Molecular Medicine

Anticancer oncolytic activity of respiratory syncytial virus

(2009) I Echchgadda et al.   CANCER GENE THERAPY

Cyclic Adenosine Monophosphate Suppresses the Transcription of Proinflammatory Cytokines via the Phosphorylated c-Fos Protein

(2009) Keiko Koga et al.   IMMUNITY

Inhibition of GSK-3β enhances reovirus-induced apoptosis in colon cancer cells

(2009) Chung   INTERNATIONAL JOURNAL OF ONCOLOGY

The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells

(2008) T Katsura et al.   CANCER GENE THERAPY

Control of canonical NF- B activation through the NIK-IKK complex pathway

(2008) B. Zarnegar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA